GARY LOEB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GARY LOEB.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GARY LOEB. GARY LOEB is a EVP, General Counsel & Sec. in SANGAMO THERAPEUTICS, INC ($SGMO) and a General Counsel in Achaogen Inc ($AKAO) and a See Remarks in Achaogen, Inc. ($AKAO) and a SVP, Gen'l Counsel & Secretary in AMYRIS, INC. ($AMRS).
Address: C/O AMYRIS, INC. 5885 HOLLIS ST., SUITE 100 EMERYVILLE 94608 CA
Companies in which GARY LOEB is an Insider
Achaogen, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GARY LOEB: See Remarks, General Counsel
Holdings: 239,673 shares
Current Value: $4,517,836
Latest Transaction: Feb 25 2019
$AKAO Market Capitalization: $541.33M
$AKAO Previous Close: $18.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AMYRIS, INC.
Industry: INDUSTRIAL ORGANIC CHEMICALS [2860]
Position of GARY LOEB: SVP, Gen'l Counsel & Secretary
Holdings: 138,389 shares
Current Value: $70,578
Latest Transaction: Jun 05 2013
$AMRS Market Capitalization: $136.77M
$AMRS Previous Close: $0.51
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SANGAMO THERAPEUTICS, INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GARY LOEB: EVP, General Counsel & Sec.
Holdings: 100,762 shares
Current Value: $387,934
Latest Transaction: Mar 25 2021
$SGMO Market Capitalization: $254.24M
$SGMO Previous Close: $3.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of GARY LOEB
Sentiment: All, AKAO, AMRS, SGMO
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 25 2021 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Option Exercise | M | 11.02 | 11,981 | 132,031 | 238,019 | |
| Mar 25 2021 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Sell | S | 13.17 | 543 | 7,152 | 83,238 | 83.8 K to 83.2 K (-0.65 %) |
| Mar 25 2021 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Sell | S | 13.18 | 5,000 | 65,901 | 83,781 | 88.8 K to 83.8 K (-5.63 %) |
| Mar 25 2021 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Sell | S | 13.10 | 11,981 | 156,989 | 88,781 | 100.8 K to 88.8 K (-11.89 %) |
| Mar 25 2021 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Buy | M | 11.02 | 11,981 | 132,031 | 100,762 | 88.8 K to 100.8 K (+13.50 %) |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Option Exercise | A | 11.19 | 88,000 | 984,720 | 88,000 | |
| Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | LOEB GARY | EVP, General Counse ... | Grant | A | 0.00 | 44,000 | 0 | 88,781 | 44.8 K to 88.8 K (+98.26 %) |